BeOne Medicines (ONC) Assets Growth (1y) (2016 - 2026)
Powered by 
Analysis
BeOne Medicines (ONC) Assets Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.54 Bn | 131.69 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.84 Bn | 77.85 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.48 Bn | 58.30 Bn | 1.37 Bn |
| 4 | Moderna | 57.80 Bn | 52.66 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 40.06 Bn | 34.96 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.43 Bn | 32.12 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.48 Bn | 27.64 Bn | - |
| 9 | Insmed | 27.37 Bn | 26.21 Bn | 358.27 Mn |
| 10 | Incyte | 25.61 Bn | 21.07 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.68% |
| Mar 31, 2026 | 46.43% |
| Dec 31, 2025 | 38.30% |
| Sep 30, 2025 | 30.90% |
| Jun 30, 2025 | 10.26% |
| Mar 31, 2025 | 3.07% |
| Dec 31, 2024 | 1.99% |
| Sep 30, 2024 | 5.54% |
| Jun 30, 2024 | -0.29% |
| Mar 31, 2024 | -4.85% |
| Dec 31, 2023 | -9.00% |
| Sep 30, 2023 | -17.86% |
| Jun 30, 2023 | -22.36% |
| Mar 31, 2023 | -25.74% |
| Dec 31, 2022 | -25.26% |
| Sep 30, 2022 | 27.23% |
| Jun 30, 2022 | 33.56% |
| Mar 31, 2022 | 37.80% |
| Dec 31, 2021 | 52.40% |
| Sep 30, 2021 | -5.03% |